By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) medications have rapidly ascended...
Patient Advocacy and Support
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
In a landmark decision that promises to reshape the standard of care for patients battling advanced malignancy,...
TORONTO, ON – As the medical community continues to make strides in early detection and targeted therapies,...
Introduction: A Growing Intersection of Health and Hope In recent years, Glucagon-like peptide-1 (GLP-1) receptor agonists, commonly...
NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global...
The landscape of metastatic breast cancer (MBC) treatment has reached a significant milestone following the U.S. Food...
Introduction As the medical community continues to make strides in the early detection and acute treatment of...
By Douglas Feil, NBCF Chief Program Officer The landscape of medical treatment is constantly evolving, and recent...
NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October,...
